the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in Malignant Effusions.

NARecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 11, 2024

Primary Completion Date

April 1, 2024

Study Completion Date

January 1, 2025

Conditions
Salmonella Bacteremia
Interventions
BIOLOGICAL

Tpdelansbsalbac

Tpdelansbsalbac,which is Knockdown of ansB, a gene that expresses L-mentholase secreted into the extracellular region, on the basis of the genetic background of bacterium VNP20009, and construction of an ansB gene-deficient mutant strain, ΔansB.

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Xinxiang Medical university, Henan Province

All Listed Sponsors
lead

The First Affiliated Hospital of Xinxiang Medical College

OTHER